Abiopharma

News list

Gage Matthew 🟢 acquired 5.0K shares (1 derivative) of Precipio, Inc. (PRPO) at $23.82 Transaction Date: Jan 02, 2026 | Filing ID: 001347

Full text

News bot Jan. 6, 2026, 10:43 p.m.
🔍 Gage Matthew (Executive)

Company: Precipio, Inc. (PRPO)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 5,000
Detailed Transactions and Holdings:
- Acquired 5,000 shares of Stock Option (Right to Buy) at $23.82 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 5,000.00 | transaction_form_type: 4 | Footnotes: F2, F1
Footnotes:
- F1: The options shall vest and become exercisable on the date that the 10-day volume-weighted average price ("VWAP") of the Company's common stock exceeds $40 per share.
- F2: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as an officer of the Issuer and has an exercise price of $23.82 per share.